SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-195697
Filing Date
2019-07-17
Accepted
2019-07-17 16:44:03
Documents
5
Group Members
AMIR NASHATJONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS FUND V, L.P.POLARIS VENTURE PARTNERS SPECIAL FOUNDERS FUND V, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d763464dsc13da.htm SC 13D/A 145373
2 EX-99.A d763464dex99a.htm EX-99.A 13844
3 EX-99.B d763464dex99b.htm EX-99.B 6160
4 EX-99.C d763464dex99c.htm EX-99.C 6164
5 EX-99.D d763464dex99d.htm EX-99.D 6148
  Complete submission text file 0001193125-19-195697.txt   179570
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Subject) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88839 | Film No.: 19959508
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A